Global Thrombelastograph Hemostasis Analyzer (TEG) Market, 2020-2026

September 2020 | 97 pages | ID: G424B254A956EN
Gen Consulting Company

Abstracts

Thrombelastograph hemostasis analyzer is a diagnostic instrument used for measuring the viscoelastic properties of the hemostasis process and allowing for individualized goal-directed therapy. According to Gen Consulting Company, global thrombelastograph hemostasis analyzer market is projected to grow at a CAGR of 6.46% during the forecast period 2020-2026. Growing potential for thrombelastograph hemostasis analyzer in hospitals industry is the chief contributor for the growth of the market.

By application, the thrombelastograph hemostasis analyzer market is classified into Hospitals, Blood Banks, Academic Institutes. On the basis of region, the thrombelastograph hemostasis analyzer industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Application:

• Hospitals
• Blood Banks
• Academic Institutes

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.

• North America (U.S., Canada, Mexico, etc.)
• Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
• Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
• South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the thrombelastograph hemostasis analyzer market. Some of the leading players profiled in the report include:

• Haemonetics Corporation
• Beijing Lepu Diagnostic Technology Co., Ltd.
• Medcaptain Medical Technology Co., Ltd.
• Guangzhou Improve Medical Instruments Co., Ltd.
• ChongQing NanFang Numericl Control Equipment Co., Ltd.
• Guizhou Jinjiu Biotechnology Co., Ltd.
• Framar Hemologix srl
• Wuhan Zhongke Hexin Biotechnology Co., Ltd.
• Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.

*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective

• To analyze and forecast the market size of global thrombelastograph hemostasis analyzer market.
• To classify and forecast global thrombelastograph hemostasis analyzer market based on application.
• To identify drivers and challenges for global thrombelastograph hemostasis analyzer market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global thrombelastograph hemostasis analyzer market.
• To conduct pricing analysis for global thrombelastograph hemostasis analyzer market.
• To identify and analyze the profile of leading players operating in global thrombelastograph hemostasis analyzer market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:

• Manufacturers of thrombelastograph hemostasis analyzer
• Raw material suppliers
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to thrombelastograph hemostasis analyzer

Contents

PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Consumers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitute Products and Services
  4.5.5 Degree of Competition

PART 7. GLOBAL MARKET FOR THROMBELASTOGRAPH HEMOSTASIS ANALYZER BY APPLICATION

7.1 Market Overview
7.2 Hospitals
  7.2.1 Market Size and Forecast
7.3 Blood Banks
  7.3.1 Market Size and Forecast
7.4 Academic Institutes
  7.4.1 Market Size and Forecast

PART 8. GLOBAL MARKET FOR THROMBELASTOGRAPH HEMOSTASIS ANALYZER BY GEOGRAPHY

8.1 Overview
  8.1.1 Market Size and Forecast
8.2 North America
  8.2.1 Market Size and Forecast
  8.2.2 North America: Thrombelastograph Hemostasis Analyzer Market by Country
    8.2.2.1 United States
    8.2.2.2 Canada
    8.2.2.3 Mexico
8.3 Europe
  8.3.1 Market Size and Forecast
  8.3.2 Europe: Thrombelastograph Hemostasis Analyzer Market by Country
    8.3.2.1 Germany
    8.3.2.2 France
    8.3.2.3 United Kingdom
    8.3.2.4 Italy
    8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
  8.4.1 Market Size and Forecast
  8.4.2 Asia-Pacific: Thrombelastograph Hemostasis Analyzer Market by Country
    8.4.2.1 China
    8.4.2.2 India
    8.4.2.3 Japan
    8.4.2.4 South Korea
    8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
  8.5.1 Market Size and Forecast
  8.5.2 MEA: Thrombelastograph Hemostasis Analyzer Market by Country
    8.5.2.1 Saudi Arabia
    8.5.2.2 South Africa
    8.5.2.3 Turkey
8.6 South America
  8.6.1 Market Size and Forecast
  8.6.2 South America: Thrombelastograph Hemostasis Analyzer Market by Country
    8.6.2.1 Brazil
    8.6.2.2 Argentina
    8.6.2.3 Rest of South America

PART 9. COMPETITIVE LANDSCAPE

9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

PART 10. KEY COMPETITOR PROFILES

10.1 Haemonetics Corporation
10.2 Beijing Lepu Diagnostic Technology Co., Ltd.
10.3 Medcaptain Medical Technology Co., Ltd.
10.4 Guangzhou Improve Medical Instruments Co., Ltd.
10.5 ChongQing NanFang Numericl Control Equipment Co., Ltd.
10.6 Guizhou Jinjiu Biotechnology Co., Ltd.
10.7 Framar Hemologix srl
10.8 Wuhan Zhongke Hexin Biotechnology Co., Ltd.
10.9 Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
*LIST IS NOT EXHAUSTIVE

PART 11. PATENT ANALYSIS

11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis

DISCLAIMER

About

ABOUT GEN CONSULTING COMPANY